Use of methotrexate in refractory Crohn's disease: The Edinburgh experience

Inflammatory Bowel Diseases

Volumn 14, Issue 6, 2008, Pages 756-762

  Din, Shahida ^a   Dahele, Anna ^a   Fennel, Janice ^a   Aitken, Sue ^a   Shand, Alan G ^a   Arnott, Ian D R ^a   Satsangi, Jack ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Crohn's disease; Methotrexate; Refractory

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CIPROFLOXACIN; DOMPERIDONE; FOLIC ACID; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; METRONIDAZOLE; PREDNISOLONE;

ABDOMINAL PAIN; ADULT; AMENORRHEA; ANEMIA; ARTHRALGIA; ARTHROPATHY; ARTICLE; BONE PAIN; CHEST INFECTION; CLINICAL ARTICLE; CONDYLOMA ACUMINATUM; CROHN DISEASE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HAIR LOSS; HEMOGLOBIN BLOOD LEVEL; HERPES; HUMAN; INFECTION; INJECTION SITE PAIN; INSOMNIA; INTERSTITIAL LUNG DISEASE; LETHARGY; LEUKOCYTE COUNT; LIVER FUNCTION TEST; LOW DRUG DOSE; MALE; MENSTRUAL IRREGULARITY; MYALGIA; NAUSEA; OSTEOPENIA; PANCREATITIS; PERIPHERAL NEUROPATHY; PNEUMONIA; PRIORITY JOURNAL; RASH; RECURRENT INFECTION; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SENSORY DYSFUNCTION; SIDE EFFECT; TOOTH ABSCESS; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VERRUCA VULGARIS; VIRAL GASTROENTERITIS; VOMITING;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; CROHN DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAMUSCULAR; MALE; METHOTREXATE; PREDNISOLONE; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 46049088744     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20405     Document Type: Article

References (29)

1. Egan LJ, Sandborn WJ. Methotrexate for inflammatory bowel disease: pharmacology and preliminary results. Mayo Clin Proc. 1996;71:69-80.
2. Chande N, Ponich T, Gregor J. A survey of Canadian gastroenterologists about the use of methotrexate in patients with Crohn's disease. Can J Gastroenterol. 2005;19:553-558.
3. Kozarek RA, Patterson DJ, Gelfand MD, et al. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med. 1989;110:353-356.
4. Baron TH, Truss CD, Elson CO. Low-dose oral methotrexate in refractory inflammatory bowel disease. Dig Dis Sci. 1993;38:1851-1856.
5. Houben MH, van Wijk HJ, Driessen WM, et al. [Methotrexate as possible treatment in refractory chronic inflammatory intestinal disease.] Ned Tijdschr Geneeskd. 1994;138:2552-2556.
6. Feagan BG, Rochon J, Fedorak RN, et al. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med. 1995;332:292-297.
7. Feagan BG, Fedorak RN, Irvine EJ, et al. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med. 2000;342:1627-1632.
8. Orlando A, Colombo E, Kohn A, et al. Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study. Dig Liver Dis. 2005;37:577-583.
9. Farrell RJ, Alsahli M, Jeen YT, et al. Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial. Gastroenterology. 2003;124:917-924.
10. Sandborn WJ. Preventing antibodies to infliximab in patients with Crohn's disease: optimize not immunize. Gastroenterology. 2003;124:1140-1145.
11. Kozarek RA. Patterson DJ, Gelfand MD, et al. Long term use of methotrexate in inflammatory bowel disease. Gastroenterology. 1992;102:A648 (abstract).
12. Lemann M, Chamiot-Prieur C, Mesnard B, et al. Methotrexate for the treatment of refractory Crohn's disease. Aliment Pharmacol Ther. 1996;10:309-314.
13. Chamiot-Prieur CLM, Mesnard B. Treatment of refractory Crohn's disease with methotrexate. Gastroenterology. 1993;104:A680 (abstract).
14. Zenjari T, Lemann M., Mesnard B, et al. Methotrexate in Crohn's disease: long term efficacy and toxicity. Gastroenterology. 1996;110:A1053 (abstract).
15. Fraser AG, Morton D, McGovern D, et al. The efficacy of methotrexate for maintaining remission in inflammatory bowel disease. Aliment Pharmacol Vier. 2002;16:693-697.
16. Kurnik D, Loebstein R, Fishbein E, et al. Bioavailability of oral vs. subcutaneous low-dose methotrexate in patients with Crohn's disease. Aliment Pharmacol Ther. 2003;18:57-63.
17. Sun JH, Das KM. Low-dose oral methotrexate for maintaining Crohn's disease remission: where we stand. J Clin Gastroenterol. 2005;39:751-756.
18. Brooks PJ, Spruill WJ, Parish RC, et al. Pharmacokinetics of methotrexate administered by intramuscular and subcutaneous injections in patients with rheumatoid arthritis. Arthritis Rheum. 1990;33:91-94.
19. Nathan DM, Iser JH, Gibson PR. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration. J Gastroenterol Hepatol. 2007 (in press).
20. Lemann M, Zenjari T, Bouhnik Y, et al. Methotrexate in Crohn's disease: long-term efficacy and toxicity. Am J Gastroenterol. 2000;95:1730-1734.
21. Balachandran C, McCluskey PJ, Champion GD, et al. Methotrexate-induced optic neuropathy. Clin Experiment Ophthalmol. 2002;30:440-441.
22. Verstappen CC, Heimans JJ, Hoekman K, et al. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs. 2003;63:1549-1563.
23. Alfaro J, Von Muhlenbrock R, Burgos N. et al. [Acute poisoning with methotrexate used as an abortifacient: description of 2 cases.] Rev Med Chil. 2000;128:315-318.
24. Te HS, Schiano TD, Kuan SF, et al. Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease. Am J Gastroenterol. 2000;95:3150-3156.
25. Oren R, Moshkowitz M, Odes S, et al. Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial. Am J Gastroenterol. 1997;92:2203-2209.
26. Arora S, Katkov W, Cooley J, et al. Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial. Hepatogastroenterology. 1999;46:1724-1729.
27. Soon SY, Ansari A, Yaneza M, et al. Experience with the use of low-dose methotrexate for inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2004;16:921-926.
28. Hayee BH, Harris AW. Methotrexate for Crohn's disease: experience in a district general hospital. Eur J Gastroenterol Hepatol. 2005;17:893-898.
29. Chong RY, Hanauer SB, Cohen RD. Efficacy of parenteral methotrexate in refractory Crohn's disease. Aliment Pharmacol Ther. 2001;15:35-44.